RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 8 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $55 | – | 314 | +2.6% | 0.00% | – |
| Q3 2022 | $0 | – | 306 | +10.1% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 278 | -99.4% | 0.00% | – |
| Q1 2022 | $242,000 | -56.7% | 43,893 | -24.0% | 0.00% | – |
| Q4 2021 | $559,000 | -34.1% | 57,781 | +21.7% | 0.00% | – |
| Q3 2021 | $848,000 | -23.3% | 47,481 | +4.9% | 0.00% | – |
| Q2 2021 | $1,105,000 | +466.7% | 45,274 | +514.4% | 0.00% | – |
| Q1 2021 | $195,000 | -18.1% | 7,369 | -76.5% | 0.00% | – |
| Q4 2020 | $238,000 | +155.9% | 31,397 | +69.7% | 0.00% | – |
| Q3 2020 | $93,000 | -16.2% | 18,503 | -0.3% | 0.00% | – |
| Q2 2020 | $111,000 | +32.1% | 18,560 | -2.5% | 0.00% | – |
| Q1 2020 | $84,000 | -54.3% | 19,029 | -1.7% | 0.00% | – |
| Q4 2019 | $184,000 | +14.3% | 19,352 | -5.6% | 0.00% | – |
| Q3 2019 | $161,000 | -47.2% | 20,502 | +6.1% | 0.00% | – |
| Q2 2019 | $305,000 | -20.4% | 19,322 | -8.8% | 0.00% | – |
| Q1 2019 | $383,000 | +294.8% | 21,176 | +250.9% | 0.00% | – |
| Q4 2018 | $97,000 | +18.3% | 6,035 | +76.4% | 0.00% | – |
| Q3 2018 | $82,000 | – | 3,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |